Figure1 (Figure1)
Losartan Potassium
Product Images NDC 50090-4048
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-4048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2 (Figure2)
This is a table showing the percentage of patients who experienced fatal or non-fatal stroke in a study conducted over a period of 66 months. The data compares the effectiveness of two medications, Atenolol and Losartan potassium. However, the table seems incomplete, as there is missing data after the name of the second medication.*
Figure3 (Figure3)
This appears to be a table showing the results of a clinical study on the primary composite stroke rate in patients taking Losartan Potassium and Atenolol. The data is broken down by age, gender, race, and medical history. The table also includes hazard ratios for each group.*
Figure4 (Figure4)
This is a statistical report on risk reduction with a value of 16.1% and a p-value of 0.022. There is a graph with two values, 40 and 20, possibly percentage of patients with an event, but the context is not provided, so it is difficult to determine the meaning of the graph.*
Label Image (Lbl500904048)
Structural-formula (Structural Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
